GenevaLunch News Basel, Switzerland (GenevaLunch) – Basel-based Roche Holdings AG, the number two Swiss pharmaceutical company announced sales growth for Q3, although lower than forecasts, due to a decline in sales of the pandemic Tamiflu vaccine. Despite the predicted sharp decline in Tamiflu sales versus the same period last year, pharmaceuticals division sales increased 4% in local […]
Roche behind forecast but still growing © GenevaLunch News, See license terms.